Harry Sacks is currently the Executive Medical Director for Immunology at Regeneron Pharmaceuticals, a position they have held since 2022. Previously, they served as the VP of Medical Affairs and Corporate Medical Officer at Optinose from 2017 to 2022, and held several key roles in respiratory medical leadership at Novartis and Forest Laboratories. With extensive experience in clinical development and medical affairs, Harry also worked as the VP of Medical and Scientific Affairs and Chief Medical Officer at Meda and as Group Director of Clinical Research at Schering-Plough Research Institute. They earned their Doctor of Medicine degree with special distinction in research from Albert Einstein College of Medicine and a Bachelor of Arts in Biology/Pre-med from Yeshiva University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices